The required genetic analyser will be used to undertake both Sanger Sequencing and Fragment Analysis including the batch release of vaccines, as part of a wider sequencing core function. The system will need to be used under the Quality control system. Actual consumable and operational spend will depend on actual work flows and demand.
- Procurement
- Genetic Analyser
- Buyer
- MHRA
- Published
- 27 Sept 2022
- Status
- complete
- CPV
- 38000000 — Laboratory, optical and precision equipments (excl. glasses)
- Tender period
- —
Awards
Other notices in this procurement
FAQs about this notice
What type of notice is this?
This is a award,contract published via Find a Tender on 27 Sept 2022.
Which procurement does this notice belong to?
It is part of "Genetic Analyser", published by MHRA.
Has this notice resulted in an award?
1 award is recorded on this notice, including to LIFE TECHNOLOGIES LIMITED.
Get the full procurement picture
Enable turns the UK's public-contract data into pipeline intelligence for bid and capture teams. Talk to us about access, alerts and tailored market analysis.
Get in touch with Enable